Sign Up Now. An unexpected error has occurred with your sign up. Please try again later. Check here if you would like to receive subscription offers and other promotions via email from TIME group companies. You can unsubscribe at any time. By signing up you are agreeing to our Terms of Service and Privacy Policy. Thank you! For your security, we've sent a confirmation email to the address you entered.
Click the link to confirm your subscription and begin receiving our newsletters. If you don't get the confirmation within 10 minutes, please check your spam folder. While taking oxymorphone, discuss with your health care provider your pain treatment goals, length of treatment, and other ways to manage your pain. Tell your doctor if you or anyone in your family drinks or has ever drunk large amounts of alcohol, uses or has ever used street drugs, or has overused prescription medications, or has had an overdose, or if you have or have ever had depression or another mental illness.
There is a greater risk that you will overuse oxymorphone if you have or have ever had any of these conditions. Talk to your healthcare provider immediately and ask for guidance if you think that you have an opioid addiction or call the U. Oxymorphone may cause serious or life-threatening breathing problems, especially during the first 72 hours of your treatment and any time your dose is increased. Your doctor will monitor you carefully during your treatment.
Tell your doctor if you have or have ever had slowed breathing, or asthma. Your doctor will probably tell you not to take oxymorphone tablets. Also tell your doctor if you have or have ever had lung disease such as chronic obstructive pulmonary disease COPD; a group of lung diseases that includes chronic bronchitis and emphysema , a head injury, brain tumor, any condition that increases the amount of pressure in your brain, or sleep apnea condition in which breathing stops or becomes shallow during sleep.
The risk that you will develop breathing problems may be higher if you are an older adult or are weak or malnourished due to disease. If you experience any of the following symptoms, call your doctor immediately or get emergency medical treatment: slowed breathing, long pauses between breaths, or shortness of breath. Taking certain medications other medications with oxymorphone may increase the risk that you will develop serious or life-threatening breathing problems, sedation, or coma.
Tell your doctor and pharmacist if you are taking or plan to take any of the following medications: benzodiazepines such as alprazolam Xanax , chlordiazepoxide Librium , clonazepam Klonopin , diazepam Diastat, Valium , estazolam, flurazepam, lorazepam Ativan , oxazepam, temazepam Restoril , and triazolam Halcion ;medications for mental illness or nausea; other narcotic pain medications; muscle relaxants; sedatives; sleeping pills; and tranquilizers.
Also tell your doctor or pharmacist if you are taking any of the following medications or have stopped taking them within the past 2 weeks: monoamine oxidase MAO inhibitors such as isocarboxazid Marplan , linezolid Zyvox , phenelzine Nardil , rasagiline Azilect , selegiline Emsam, Eldepryl, Zelapar , and tranylcypromine Parnate.
Your doctor may need to change the doses of your medication and will monitor you carefully. If you take oxymorphone with any of these medications and you develop any of the following symptoms, call your doctor immediately or seek emergency medical care: unusual dizziness, lightheadedness, extreme sleepiness, slowed or difficult breathing, or unresponsiveness.
Be sure that your caregiver or family members know which symptoms may be serious so they can call the doctor or emergency medical care if you are unable to seek treatment on your own.
Drinking alcohol, taking prescription or nonprescription medications that contain alcohol, or using street drugs during your treatment with oxycodone increases the risk that you will experience serious, life-threatening side effects.
Do not drink alcohol, take prescription or nonprescription medications that contain alcohol, or use street drugs during your treatment. Do not allow anyone else to take your medication. Oxymorphone may harm or cause death to other people who take your medication, especially children. Store oxymorphone in a safe place so that no one else can take it accidentally or on purpose.
Be especially careful to keep oxymorphone out of the reach of children. Keep track of how many tablets, or capsules are left so you will know if any medication is missing. Tell your doctor if you are pregnant or plan to become pregnant.
If you take oxymorphone regularly during your pregnancy, your baby may experience life-threatening withdrawal symptoms after birth. Tell your baby's doctor right away if your baby experiences any of the following symptoms: irritability, hyperactivity, abnormal sleep, high-pitched cry, uncontrollable shaking of a part of the body, vomiting, diarrhea, or failure to gain weight. Your doctor or pharmacist will give you the manufacturer's patient information sheet Medication Guide when you begin treatment with oxymorphone and each time you fill your prescription.
Read the information carefully and ask your doctor or pharmacist if you have any questions. Oxymorphone is used to relieve moderate to severe pain in people whose pain is not controlled with other medications.
Oxymorphone is in a class of medications called opiate narcotic analgesics. It works by changing the way the body responds to pain. Oxymorphone comes as a tablet and as an extended-release long-acting tablet to take by mouth on an empty stomach, at least 1 hour before or 2 hours after meals. It is usually taken every 4 to 6 hours. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand.
Do not take more or less of it or take it more often than prescribed by your doctor. The arrangement was criticized as appearing to be pay-for-play connection between regulators and companies anxious to get products onto the multibillion-dollar-a-year pain market.
In , two U. A researcher at the school was a co-founder of the group. Joe Manchin D-W. David Vitter R-La. Though the meetings were invitation-only, he said, they were attended by a variety of government officials, academics, and pain advocates.
He said the meetings had no bearing on the approval of Opana and did not include the discussion of any particular product or the standards for FDA approval of pain products. The approach allows drugs companies to weed out people who don't respond well to a drug or who can't tolerate taking it before an actual clinical trial for the drug begins. Independent doctors say that approach makes it much more likely a drug will be found effective and possibly win FDA approval.
It's also cheaper for drug companies to conduct such trials. Critics say the approach essentially stacks the deck in favor of the drug. More importantly, experts say, drugs tested that way are not likely to reflect what will happen when a medication gets on the market and is prescribed for large numbers of people. When Endo tried to get Opana approved in , the FDA said the drug didn't appear effective enough in clinical trials. It also raised safety concerns after several postoperative pain patients overdosed on the drug and had to be revived with naloxone.
0コメント